Addus HomeCare (ADUS) Set to Announce Earnings on Monday

Addus HomeCare (NASDAQ:ADUS - Get Free Report) is set to announce its earnings results after the market closes on Monday, November 4th. Analysts expect Addus HomeCare to post earnings of $1.14 per share for the quarter. Investors that are interested in participating in the company's conference call can do so using this link.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.21 by $0.14. The business had revenue of $286.90 million during the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.94 earnings per share. On average, analysts expect Addus HomeCare to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS traded up $0.33 during midday trading on Monday, hitting $128.29. The company's stock had a trading volume of 124,905 shares, compared to its average volume of 130,926. Addus HomeCare has a 12-month low of $78.35 and a 12-month high of $136.12. The company has a market cap of $2.32 billion, a P/E ratio of 31.95, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04. The business's 50 day simple moving average is $130.54 and its 200 day simple moving average is $119.40.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ADUS shares. KeyCorp assumed coverage on Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price target for the company. Macquarie reissued an "outperform" rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Friday, October 11th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $141.00 target price on shares of Addus HomeCare in a research note on Tuesday, September 3rd. StockNews.com cut shares of Addus HomeCare from a "strong-buy" rating to a "buy" rating in a research note on Sunday, July 7th. Finally, TD Cowen upped their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a "buy" rating in a report on Thursday, August 8th. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Addus HomeCare currently has a consensus rating of "Moderate Buy" and a consensus target price of $131.38.

Insider Buying and Selling

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business's stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Esteban Lopez sold 500 shares of the company's stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the sale, the director now directly owns 3,866 shares in the company, valued at $502,695.98. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 22,917 shares of company stock valued at $3,050,082. Corporate insiders own 4.60% of the company's stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.